Individualising Therapy to Minimize Bacterial Multidrug Resistance.

Heffernan, A J; Sime, F B; Lipman, J; Roberts, J A

Heffernan, A J; Sime, F B; Lipman, J; Roberts, J A.

Affiliation

Heffernan AJ; School of Medicine, Griffith University, Gold Coast, Queensland, Australia.
Sime FB; Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia.
Lipman J; Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia.
Roberts JA; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Building 71/918, Herston Rd, Herston, Queensland, 4029, Australia.

Drugs ; 78(6): 621-641, 2018 Apr.

Article in En | MEDLINE | ID: mdl-29569104

Subject(s)

Anti-Bacterial Agents/therapeutic use; Drug Resistance, Multiple, Bacterial/drug effects; Precision Medicine/methods; Aminoglycosides/pharmacokinetics; Aminoglycosides/therapeutic use; Anti-Bacterial Agents/pharmacokinetics; Biomarkers/metabolism; Drug Therapy, Combination; Fluoroquinolones/pharmacokinetics; Fluoroquinolones/therapeutic use; Humans; Microbial Sensitivity Tests/methods; Molecular Targeted Therapy; Procalcitonin/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Resistance, Multiple, Bacterial / Precision Medicine / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Drugs Year: 2018 Document type: Article

Fulltext

XML

PubMed Links

Search on Google